By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genzyme Biosurgery 

500 Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-252-7500 Fax: 617-252-7600


Company News
Sanofi (France) (SASY.PA) and Genzyme Biosurgery Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio(TM)(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity 10/6/2011 6:59:56 AM
Genzyme Biosurgery Shareholders Receive $64 Million Settlement in Victory Over Genzyme Corporation (GENZ) 1/13/2009 6:36:19 AM
Genzyme Corporation (GENZ) Files for Approval of Single-Treatment Synvisc-One(TM) 6/20/2007 11:42:50 AM
Genzyme Corporation (GENZ) Begins Phase 2 Gene Transfer Trial For Peripheral Arterial Disease10/19/2005 5:12:49 PM
Genzyme Corporation (GENZ) Completes Acquisition Of ILEX Oncology, Inc. (GENZ)10/19/2005 5:12:30 PM
Genzyme Corporation (GENZ) Recognized As A Top Employer By Scientists For Second Consecutive Year10/19/2005 5:12:19 PM
Genzyme Corporation (GENZ) Reports Strong Fourth-Quarter Revenue Growth10/19/2005 5:12:12 PM
Genzyme Corporation (GENZ) Completes Purchase Of Synvisc Sales and Marketing Rights10/19/2005 5:11:56 PM
Ash Stevens Inc. To Manufacture New Cancer Drug10/19/2005 5:11:34 PM
The Day In Review: Genentech, Inc. (DNA) Drives Biotech Higher10/19/2005 5:10:53 PM